In the mouse brain, NR4A1 protects dopaminergic neurons in a rodent model of Parkinson’s disease and delays the onset of clinical symptoms of experimental autoimmune encephalomyelitis (EAE) by inhibiting microglial activation and proinflammatory gene expression [12,13]. This evidence concerns the gene NR4A1 and Parkinson disease.